NCT06644768
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06644768
Title A Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic Alterations
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Daiichi Sankyo
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | BRA | ARG

Facility Status City State Zip Country Details
University of California San Diego (Ucsd)-Moores Cancer Center La Jolla California 92037 United States Details
California Research Institute Los Angeles California 90027 United States Details
Valkyrie Clinical Trials Los Angeles California 90067 United States Details
Mayo Clinic Hospital Jacksonville Florida 32224 United States Details
BRCR Global Plantation Florida 33322-5426 United States Details
University of Kentucky Medical Center Lexington Kentucky 40536 United States Details
Pikeville Medical Center Pikeville Kentucky 41501 United States Details
Mayo Clinic - Rochester Rochester Minnesota 55904 United States Details
Columbia University Irving Medical Center New York New York 10032 United States Details
Thomas Jefferson University, Sidney Kimmel Cancer Center Philadelphia Pennsylvania 19107 United States Details
Virginia Cancer Specialist Fairfax Virginia 22031 United States Details
Hospital Italiano de Buenos Aires Buenos Aires 1199 Argentina Details
Instituto Alexander Fleming Buenos Aires 1426 Argentina Details
Sanatorio Allende Córdoba X5000JHQ Argentina Details
Fundacion Ars Medica N Salvador de Jujuy 4600 Argentina Details
Instituto Medico de La Fundacion Estudios Clinicos Rosario 2000 Argentina Details
Clinica Viedma S.A. Viedma R8500ACE Argentina Details
Centro de Pesquisas Clinica Reichow Blumenau 89010-340 Brazil Details
Clínica de Neoplasias Litoral Ltda. ItajaĂ- 88301-220 Brazil Details
CINPAM Centro Integrado De Pesquisa Da Amazonia Manaus 69005-080 Brazil Details
Liga Norte-Rio-Grandense Contra o Câncer Natal 59062-000 Brazil Details
Hospital Nossa Senhora da Conceicao Porto Alegre 91350-280 Brazil Details
Fundacao Faculdade Regional de Medicina de Sao Jose Do Rio Preto Sao Jose Rio Preto 15090-000 Brazil Details
Jilin Cancer Hospital Changchun 130000 China Details
Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine Hangzhou 242332 China Details
Harbin Medical University Cancer Hospital Harbin 150081 China Details
Jiamusi Cancer Hospital Jiamusi 154007 China Details
Shanghai East Hospital Shanghai 200120 China Details
Tianjin Medical University Cancer Institute & Hospital Tiyuan 300060 China Details
Henan Cancer Hospital Zhengzhou 450003 China Details
Kyushu University Hospital Fukuoka 812-8582 Japan Details
National Cancer Center Hospital East Kashiwa 277-8577 Japan Details
Cancer Institute Hospital of JFCR Kōtoku 135-8550 Japan Details
NHO Nagoya Medical Center Nagoya 460-0001 Japan Details
Kitasato University Hospital Sagamihara-shi 252-0375 Japan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field